Cargando…

Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I

Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized by the occurrence of nerve sheath tumors and considerable clinical heterogeneity. Some translational studies have been limited by the lack of animal models available for assessing patient-specific mutations. In order to test t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kairong, Turner, Ashley N., Chen, Min, Brosius, Stephanie N., Schoeb, Trenton R., Messiaen, Ludwine M., Bedwell, David M., Zinn, Kurt R., Anastasaki, Corina, Gutmann, David H., Korf, Bruce R., Kesterson, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958313/ https://www.ncbi.nlm.nih.gov/pubmed/27482814 http://dx.doi.org/10.1242/dmm.025783

Ejemplares similares

Updated nomenclature for human and mouse neurofibromatosis type 1 genes
por: Anastasaki, Corina, et al.
Publicado: (2017)

RAS and beyond: the many faces of the neurofibromatosis type 1 protein
por: Anastasaki, Corina, et al.
Publicado: (2022)

Commentary: Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I
por: Anastasaki, Corina, et al.
Publicado: (2019)

Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1
por: Osum, Sara H., et al.
Publicado: (2023)

Putting a stop to nonsense: Revisiting gene correction therapy for neurofibromatosis type 1
por: Gutmann, David H.
Publicado: (2023)

Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I
por: Leier, André, et al.
Publicado: (2022)

Mutation-Directed Therapeutics for Neurofibromatosis Type I
por: Leier, Andre, et al.
Publicado: (2020)

Familial Lipomas Without Classic Neurofibromatosis-1 Caused by a Missense Germline NF1 Mutation
por: Ramirez, Erika, et al.
Publicado: (2021)

Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1
por: Anastasaki, Corina, et al.
Publicado: (2022)

Statins, bone, and neurofibromatosis type 1
por: Korf, Bruce R
Publicado: (2008)

Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples
por: Gorlov, Ivan P., et al.
Publicado: (2018)

KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth
por: Anastasaki, Corina, et al.
Publicado: (2017)

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
por: Legius, Eric, et al.
Publicado: (2021)

Independent NF1 mutations underlie café-au-lait macule development in a woman with segmental NF1
por: Freret, Morgan E., et al.
Publicado: (2018)

Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
por: Isakson, Sara H., et al.
Publicado: (2018)

Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense Suppression
por: Keeling, Kim M., et al.
Publicado: (2013)

Respiratory Diseases of Rodents
por: Schoeb, Trenton R.
Publicado: (2000)

Re‐evaluation of missense variant classifications in NF2
por: Sadler, Katherine V., et al.
Publicado: (2022)

Children with 5′-end NF1 gene mutations are more likely to have glioma
por: Anastasaki, Corina, et al.
Publicado: (2017)

Brain tumors in neurofibromatosis type 1
por: Costa, Amanda De Andrade, et al.
Publicado: (2019)

Missense and Nonsense Mutations of P53 Gene in Patients with Colorectal Adenocarcinoma in Isfahan, Central Iran
por: Golmohammadi, R, et al.
Publicado: (2011)

Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting
por: Kalamarides, Michel, et al.
Publicado: (2011)

Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type II
por: Koczkowska, Magdalena, et al.
Publicado: (2023)

Generation of human induced pluripotent stem cell-derived cerebral organoids for cellular and molecular characterization
por: Anastasaki, Corina, et al.
Publicado: (2022)

FATP4 missense and nonsense mutations cause similar features in Ichthyosis Prematurity Syndrome
por: Sobol, Maria, et al.
Publicado: (2011)

Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases
por: Schoeb, Trenton R., et al.
Publicado: (2012)

Using the Neurofibromatosis Tumor Predisposition Syndromes to Understand Normal Nervous System Development
por: Garcia, Cynthia, et al.
Publicado: (2014)

ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function
por: de Majo, Martina, et al.
Publicado: (2018)

Independent inactivation of arginine decarboxylase genes by nonsense and missense mutations led to pseudogene formation in Chlamydia trachomatis serovar L2 and D strains
por: Giles, Teresa N, et al.
Publicado: (2009)

Unusual presentation of hereditary leiomyomatosis mimicking neurofibromatosis
por: Bevans, Stephanie L., et al.
Publicado: (2018)

Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects
por: Tang, Yunshuo, et al.
Publicado: (2023)

Predictive Modeling for Clinical Features Associated With Neurofibromatosis Type 1
por: Morris, Stephanie M., et al.
Publicado: (2021)

Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers
por: Bewley, Alice F., et al.
Publicado: (2022)

A patient with a novel homozygous missense mutation in FTO and concomitant nonsense mutation in CETP
por: Çağlayan, Ahmet Okay, et al.
Publicado: (2016)

Association of Pathogenic Missense and Nonsense Mutations in Mitochondrial COII Gene with Familial Adenomatous Polyposis (FAP)
por: Shaker Ardakani, Zahra, et al.
Publicado: (2020)

Phenotypical and Myopathological Consequences of Compound Heterozygous Missense and Nonsense Variants in SLC18A3
por: Della Marina, Adela, et al.
Publicado: (2021)

The NF1 Gene Contains Hotspots for L1 Endonuclease-Dependent De Novo Insertion
por: Wimmer, Katharina, et al.
Publicado: (2011)

Constitutional mismatch repair deficiency is the diagnosis in 0.41% of pathogenic NF1/SPRED1 variant negative children suspected of sporadic neurofibromatosis type 1
por: Perez-Valencia, Juan A., et al.
Publicado: (2020)

Complex splicing pattern generates great diversity in human NF1 transcripts
por: Vandenbroucke, Ina, et al.
Publicado: (2002)

An Update on Neurofibromatosis Type 1-Associated Gliomas
por: Lobbous, Mina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uc38mu85rc96rr3k1lactadpqj